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Abstract Quantitative PCR (qPCR) is an important tool in
pathogen detection. However, the use of different qPCR com-
ponents, calibration materials and DNA extraction methods
reduces comparability between laboratories, which can result
in false diagnosis and discrepancies in patient care. The wider
establishment of a metrological framework for nucleic acid
tests could improve the degree of standardisation of pathogen
detection and the quantification methods applied in the clini-
cal context. To achieve this, accurate methods need to be de-
veloped and implemented as reference measurement proce-
dures, and to facilitate characterisation of suitable certified
reference materials. Digital PCR (dPCR) has already been
used for pathogen quantification by analysing nucleic acids.
Although dPCR has the potential to provide robust and accu-
rate quantification of nucleic acids, further assessment of its
actual performance characteristics is needed before it can be
implemented in a metrological framework, and to allow ade-
quate estimation of measurement uncertainties. Here, four lab-
oratories demonstrated reproducibility (expanded measure-
ment uncertainties below 15%) of dPCR for quantification
of DNA from human cytomegalovirus, with no calibration
to a common reference material. Using whole-virus material
and extracted DNA, an intermediate precision (coefficients of
variation below 25%) between three consecutive experiments
was noted. Furthermore, discrepancies in estimated mean
DNA copy number concentrations between laboratories were
less than twofold, with DNA extraction as the main source of
variability. These data demonstrate that dPCR offers a repeat-
able and reproducible method for quantification of viral DNA,
and due to its satisfactory performance should be considered
as candidate for reference methods for implementation in a
metrological framework.
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Introduction
Nucleic acid amplification-based tests offer an important
method for rapid and reliable diagnosis of infectious diseases.
Quantitative polymerase chain reaction (qPCR) has become a
valuable tool for routine microbiology testing, as it allows
rapid, specific and sensitive detection and quantification of
viral and bacterial nucleic acids in a broad range of samples
[1–3]. However, clinical laboratories often use different qPCR
platforms, different commercial or in-house calibration mate-
rials (e.g. secondary reference materials), and different PCR
components, which can in turn result in significant variability
of the reported quantitative (i.e. concentration of pathogen)
and qualitative (i.e. presence or absence of pathogen) data
between laboratories [2, 4, 5]. Lack of agreement in reported
quantitative data hampers the definition of generally accepted
clinical thresholds for initiation or termination of anti-
pathogen therapies, while disparities in qualitative data can
result in misdiagnosis of a disease [4].
The establishment of a reference measurement system for
nucleic acid amplification-based tests through the develop-
ment of reference measurement procedures and suitable refer-
ence materials would facilitate standardisation of quantitative
and qualitative measurements within the international clinical
community. Metrological traceability of end-user measure-
ments to reference measurement procedures, that have been
used to value assign reference materials of higher metrological
order, could enhance equivalence of measurements over time
and space [6]. Suitable reference materials with assigned
values that are traceable to the International System of Units
(SI units) or to other internationally accepted standards (e.g.
international units; IU) would facilitate accurate and reproduc-
ible characterisation of reference materials at a lower level in
the calibration hierarchy and/or of calibrators produced by
different manufacturers [6, 7]. This should, in turn, increase
agreement between end-user quantitative measurements and
improve assessment of the analytical performance character-
istics of quantitative and qualitative nucleic acid
amplification-based methods [4]. Additionally, reference mea-
surement procedures that have well-defined measurement un-
certainty and are independent of external calibrators are need-
ed to provide reproducible, precise and accurate enumeration
and characterisation of reference materials of higher metrolog-
ical order, including assessment of their homogeneity and sta-
bility over time [4, 6].
For a small number of more important viruses, reference
materials that are composed of either cultured whole virus
(World Health Organisation, WHO International Reference
Materials) or plasmids (National Institute of Standards and
Technology; NIST) have already been developed, traceable
to arbitrary assigned international units (IU, byWHO), or SI
units in terms of plasmid copy numbers (NIST) [8–10].
However, for the great majority of viruses and bacteria, suit-
able reference materials for calibration purposes have not
been developed yet, while with human cytomegalovirus
(HCMV), there remains discordance for the viral loads be-
tween the different commercial reference materials [7]. As
the value assignments of the existing WHO reference mate-
rials were performed in collaborative studies using various
qPCR-based methods calibrated against arbitrary assigned
external calibrators [8], there is a challenge as neither the
qPCR method nor the external calibrator are anchored in an
unbiased way to a uniform reference. Consequently, value
assignment of different batches of calibrators and in vitro
diagnostics is challenging; a factor that could be rectified if
a suitable reference method was available and provided the
intermediate reference materials and calibrators are suited to
allow unbiased value transfer.
Digital (d)PCR has the potential to provide accurate and
robust end-point measurements of nucleic acid copy number
concentration and is therefore a promising candidate for a
reference measurement procedure. It has been demonstrated
that dPCR is more resistant (although not completely insensi-
tive) to PCR inhibitors than qPCR [11, 12]; hence, it is ex-
pected to deliver more robust and accurate nucleic acid quan-
tification than qPCR [13]. However, the reported over-
estimation and under-estimation of nucleic acid copy number
concentration indicate the need for optimisation of the analyt-
ical process of dPCR, so that homogenous distributions of
nucleic acids can be achieved during partitioning, along with
their successful amplification during the PCR cycling [14, 15].
dPCR has already been used for different applications, such as
quantification of viruses and bacteria [16–18], quantification
of virus reference materials [7, 19, 20] and value assignment
of certified reference materials that consist of plasmid DNA
[10, 14, 21]. However, as with every novel technology, com-
prehensive inter-laboratory assessments with different dPCR
platforms need to be conducted to confirm the suitability of
dPCR-based methods for value assignment of reference ma-
terials for viruses and bacteria.
In the present study, inter-laboratory comparisons were
conducted to determine the intermediate precision and repro-
ducibility of different dPCR platforms for quantification of
DNA extracted from a reference material from HCMV. Two
HCMV test materials were used in four National Metrology
Institutes (Fig. 1): whole-virus material (WVM), which was
purchased from the manufacturer individually by each labora-
tory for subsequent ‘local’ DNA extraction (henceforth
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referred to as the ‘locally extracted WVM units’); and geno-
mic DNA (gDNA), which was ‘centrally’ extracted from a
single WVM unit in the National Institute of Biology (NIB)
laboratory (Fig. 1, Table 1, laboratory 1), and aliquoted into
the ‘gDNA units’ that were distributed to the collaborating
laboratories (henceforth referred to as the ‘centrally prepared
gDNA units’). In each participating laboratory, DNA quanti-
fication of the locally extracted WVM units and the centrally
prepared gDNA units was performed using one or two of the
following dPCR platforms: a droplet-based dPCR system
(QX100 Droplet Digital PCR; Bio-Rad); and two chip-based
dPCR systems (Biomark HD, Fluidigm; QuantStudio 3D
Digital PCR, Thermo Fisher Scientific). Three units of each
HCMV test material (as both the locally extractedWVM units
and the centrally prepared gDNA units) were analysed on
each dPCR instrument as three consecutive experiments, to
determine the inter-unit variability and inter-experiment vari-
ability (i.e. intermediate precision, considering single unit
measured in three experiments in duplicate) within each in-
strument. Additionally, to determine the reproducibility of the
dPCR for each test material, and thus the potential for charac-
terisation and value assignment of reference materials, the
Fig. 1 Schematical overview of
the inter-laboratory assessment
for Awhole-virus material
(WVM) and B genomic DNA
(gDNA). With both HCMV test
materials, the procedure presented
for unit 5 was also applied to all of
the other units (for WVM and
gDNA; omitted here for clarity).
For each HCMV test material
within each laboratory, at least
one of the two platforms shown
was used
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mean HCMV DNA copy number concentrations and corre-
sponding measurement uncertainties were estimated using the
data from all five dPCR instruments.
Materials and methods
Test materials
Whole HCMV material for local DNA extraction
For the quantification of the locally extracted HCMV DNA
fromWVM, laboratory 1 obtained five units of the FirstWorld
Health Organisation International Standard for Human
Cytomegalovirus for Nucleic Acid Amplification
Techniques (i.e. four WVM units) from the WHO (code, 09/
162; UK), and each collaborating laboratory obtained four
WVM units (Fig. 1, Table 1, laboratories 2–4). Each of these
WVM units of the HCMV standard comprised the lyophilised
equivalent of 1 mL of a whole-virus preparation of the HCMV
‘Merlin’ strain that was resuspended in 10 mM Tris-HCl buff-
er (pH 7.4) with 0.5% (v/v) human serum albumin. The mate-
rial had been assigned a nominal HCMV concentration of 5 ×
106 IU/mL when reconstituted in 1 mL nuclease-free water,
based on data from an international collaborative study. The
uncertainty of the vial content determined by the manufacturer
was ±0.23%. The material was shown to be stable during its
shipment at ambient temperatures.
Centrally prepared HCMV genomic DNA
HCMV gDNA was centrally prepared at laboratory 1 (NIB;
Fig. 1B, Table 1) by extraction of the gDNA from one WVM
unit, followed by circulation of the prepared gDNA units to
the participating laboratories. To prepare the gDNA units, one
ofWVMunits (i.e., Fig. 1B, unitW10) obtained by laboratory
1 from WHO (code, 09/162; UK) was used. After opening of
WVM unit, the contents were reconstituted in 1 mL double-
distilled water, followed by fivefold dilution in phosphate-
buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 8 mM
Na2HPO4, 2 mM KH2PO4, pH 7.4). This material was then
divided into 22× 200-μL aliquots, from where the gDNAwas
extracted on the same day using QIAamp DNA Mini kits
(Qiagen). These extractions were carried out according to
the manufacturer instructions, except for the DNA elution,
where only 50 μL elution buffer was used (instead of
200 μL). The extracted HCMV gDNA was then pooled,
mixed and aliquoted into 50-μL aliquots (i.e. the gDNA
units). The concentration of the HCMV gDNAwas assigned
during the homogeneity assessment, for which five of these
gDNA units were tested (see Electronic Supplementary
Material (ESM), Method S1, gDNA units H1–H5). The re-
maining gDNA units were stored at −20 °C for 4 months.
Eight of these gDNA units were then sent on dry ice to two
of the collaborating laboratories (Fig. 1, Table 1, laboratories
2, 4), as four gDNA units for each laboratory, while four of
these gDNA units remained at laboratory 1.
Participating laboratories and dPCR platforms
Four National Metrology Institutes participated in this collab-
orative study: laboratory 1, National Institute of Biology
(NIB), Slovenia (the ‘central’ laboratory); laboratory 2, Joint
Research Centre, European Commission, Directorate F.
Retieseweg, European Union; laboratory 3, LGC (formerly
Laboratory of the Government Chemist), United Kingdom;
and laboratory 4, National Metrology Institute of Turkey
(TUBITAK UME), Turkey. The dPCR platforms used and
the materials tested (i.e., WVM units and gDNA units) by
each of these participating laboratories are shown in Table 1.
Experimental workflow
Three of the collaborating laboratories (Fig. 1, Table 1, labo-
ratories 1–3) obtained at least four WVM units from the man-
ufacturer and two participating laboratories (Fig. 1, Table 1,
laboratories 2 and 4) also received four gDNA units from
laboratory 1. One of each of these WVM units and gDNA
Table 1 Participating
laboratories, dPCR platforms and
HCMV test materials analysed in
this study
Lab. Institute Country dPCR platform Manufacturer Material
analysed




















NIB National Institute of Biology; Directorate F Joint Research Centre, European Commission; LGC (formerly
Laboratory of the Government Chemist); TUBITAK UME National Metrology Institute of Turkey;WVM whole-
virus material; gDNA genomic DNA
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units of the test materials was used for preliminary analysis of
the analytical protocol, with the remaining three WVM units
(e.g. Fig. 1A, units W1–W9) and gDNA units (e.g. Fig. 1B,
units G1–G9) of each test material used in the collaborative
study. Two vials with mixed primers and probes were also
received by each collaborating laboratory (from laboratory
1) on dry ice (see below). The complete experimental
workflow is shown schematically in Fig. 1. In each laboratory
for each dPCR instrument, three WVM units and/or three
gDNA units were included in this analysis. For each dPCR
instrument, three experiments were performed on different
days over a short period of time. In each experiment, three
aliquots were tested simultaneously, with each derived from a
different WVM or gDNA unit (e.g. Fig. 1B, experiment 1,
aliquot 1 from unit G1, aliquot 1 from unit G2, aliquot 1 from
unit G3). Laboratories 1 and 2 examined both test materials in
the same experiment.
DNA extraction of WVM units and aliquot preparation
In laboratory 1 and upon arrival at the collaborating laborato-
ries (laboratories 2, 3), each WVM unit (e.g. Fig. 1A, units
W1–W9) was opened and diluted in 1 mL double-distilled
water, as stated by the manufacturer (final nominal HCMV
concentration, 5 × 106 IU/mL). At least 200 μL of this pre-
pared material was additionally diluted fivefold in PBS (each
collaborating laboratory used either the same PBS as for the
laboratory 1 units, or purchased PBS from a manufacturer), to
reach the nominal HCMV concentration of 1 × 106 IU/mL.
For each diluted material, DNA extraction was performed
using High Pure Viral Nucleic Acid kits (Roche), according
to the manufacturer instructions. Immediately after the elution
of the DNA, each of three tubes with 50-μL eluted DNAwas
aliquoted as described below. Additionally, in each participat-
ing laboratory (laboratories 1, 2, 3), 200 μL negative extrac-
tion control (40 μL double-distilled diluted in 160 μL PBS)
was extracted using High Pure Viral Nucleic Acid kits
(Roche) simultaneouslywith the extraction of theWVMunits.
Following the extraction, the negative extraction control was
aliquoted into nine 5 μL aliquots for subsequent analysis.
Aliquot preparation and dilutions of test materials
In each laboratory, from each locally extracted gDNA (50-μL
eluted volume) from eachWVM unit, and from each centrally
prepared 50-μL gDNA unit, six aliquots were prepared (e.g.
Fig. 1A, aliquots 1–6 from unit W5), by dividing the 50-μL
volume into six low-binding microcentrifuge tubes (aliquot
volumes used for dPCR platforms: QX100, ∼6 μL;
Biomark, ∼9 μL; QuantStudio 3D, ∼9 μL). All of the aliquots
were then stored at −20 °C. For each dPCR instrument, three
aliquots from the same WVM unit or gDNA unit were each
analysed in one of three consecutive experiments on the same
dPCR instrument, over a short period of time. Each aliquot
was thawed, gravimetrically diluted in double-distilled water
and analysed on the same day.
On the QX100 system, for quantification of the aliquots
(derived from both the WVM units and the gDNA units),
10-fold gravimetric dilutions were made of each one on the
day of the analysis. For the analysis on the Biomark system,
undiluted aliquots derived from the WVM units and the
gDNA units were used. In case of QuantStudio 3D system,
2.3-fold diluted aliquots of gDNA units were used. Each par-
ticipating laboratory reported all of their gravimetric dilutions
in Excel 2007 data submission spreadsheets (ESM, Tables S1-
S6).
PCR assay for dPCR
In all of the experiments, the same UL54 assay was used for
quantification of the HCMV DNA in the WVM units and the
gDNA units, which targets the DNA polymerase (UL54) gene
of HCMV [22] (ESM, Table S7). The UL54 assay had been
assessed previously for its robustness on the QX100 system
and the Biomark system, with well-defined dynamic ranges
and limits of quantification and detection obtained [23].
Laboratory 1 prepared 20-fold concentrated mixtures of
600 nM oligonucleotide primers, and 200 nM probes which
were mixed, aliquoted (75-μL aliquots) and stored at −20 °C.
Two aliquots were then shipped to each of the collaborating
laboratories (laboratories 2–4) on dry ice, where they were
stored at −20 °C.
dPCR
Three different dPCR platforms were used in this study
(Table 1). Two laboratories used a droplet-based dPCR plat-
form (laboratories 1, 2; QX100 system, Bio-Rad), three labo-
ratories used a chip-based dPCR platform from Fluidigm (lab-
oratories 1–3; qdPCR 37K Integrated Fluidic Circuits for the
Biomark system; henceforth referred to as the Biomark 37K
array), and one laboratory used a chip-based dPCR platform
from Thermo Fisher Scientific (laboratory 4; QuantStudio 3D
system). For each instrument, the experiments were per-
formed according to the guidelines from the minimum infor-
mation for publication of quantitative digital PCR experi-
ments (ESM, Table S8).
For the Biomark 37K array, 8-μL reactions with excess
volume were used, which comprised 2 μL 4× TaqMan Fast
Virus 1-Step Master Mix (Thermo Fisher Scientific); 0.4 μL
20× UL54 assay; 0.8 μL GE Sample Loading Reagent
(Fluidigm); 2 μL double-distilled water; and 2.8 μL sample.
In each experiment, three no template controls (NTCs) and
three aliquots of the negative extraction control were included.
As only 24 samples were pipetted into the 48-inlet arrays, the
remaining 24 inlets were filled with no template reaction mix,
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to avoid baseline problems (5-μL reactions with excess vol-
ume composed of 1.25 μL 4× TaqMan Fast Virus 1-Step
Master Mix, 0.5 μL GE Sample Loading Reagent, and
3.25 μL double-distilled water). During the array loading,
only 4-μL reactions were loaded into the 770 chambers of
each inlet, while the excess reaction volume served to reduce
the bias that can arise from small pipetting volumes. The re-
actions were performed using universal conditions: 2 min at
50 °C, 10 min at 95 °C, followed by 45 cycles of 15 s at 95 °C
and 1 min at 60 °C. Ramp rate was set to 2 °C/s. The analyses
were performed using different versions of Biomark HD Data
Collection Software (Fluidigm). Each participating laboratory
reported the version of the analysis software, the fluorescence
threshold, the quality threshold, the accepted Cq range, the
baseline correction method and the number of positive ampli-
fications per panel, with all included in their data submission
Excel 2007 spreadsheets (ESM, Table S9).
For the QX100 system, 20-μL reactions were used, com-
posed of 10 μL 2× ddPCR Supermix for Probes (Bio-Rad
Laboratories, USA); 1 μL 20× UL54 assay; 1 μL double-
distilled water; and 8 μL sample. Three NTCs were included
in each experiment. The reactions were performed using the
same universal conditions as for the Biomark system, except
for the addition of a single incubation of 10 min at 98 °C at the
end of the cycling. Each participating laboratory reported the
version of QuantaSoft analysis software used (Bio-Rad), the
method for determination of the fluorescence threshold (man-
ual or automatic), the fluorescence threshold, the number of
accepted droplets and the number of positive droplets, with all
included in their data submission Excel 2007 spreadsheets
(ESM, Table S10). Additionally, each laboratory reported
2D charts of each experiment to allow exclusion of measure-
ments with abnormally increased droplet fluorescence [14]
(ESM, Fig. S1).
For the QuantStudio 3D (TUBITAK UME only), 15-μL
reactions were used, composed of 7.5 μL 2× QuantStudio
3D Digital PCR Master Mix kits (Thermo Fisher
Scientific.); 0.75 μL 20× UL54 assay; and 6.75 μL sample.
These were loaded into the QuantStudio 3D Digital Chips
(version 1). Two NTCs were included in each experiment.
The reactions were carried out under the following cycling
conditions: 10 s at 96 °C, 39 cycles of 60 s at 60 °C and
30 s at 96 °C and 10 min at 60 °C. For each chip/reaction,
three readings were used and the means of the three readings
are given in ESM, Table S6. The analyses were performed
with QuantStudio 3D AnalysisSuite Software version 1.1.1
(Thermo Fisher Scientific), the quality threshold was set to
0.5 in the ‘colour by quality’ mode and an automatically cal-
culated threshold was used in the ‘colour by calls’ mode to
separate the positive and negative signals. The number of
negative chambers and the number of qualified chambers after
application of the quality threshold setting were reported, with
all included in the data submission Excel 2007 spreadsheets.
A more recent update from manufacturer on the partition vol-
ume (0.809 nL) was used for estimation of the DNA copy
number concentration, instead of the partition volume of
0.865 nL that was the announced chip-partition volume of
the first version of the QuantStudio 3D Chip kit.
Analysis of results
Calculation of DNA copy number concentration
For each of the laboratories and dPCR instruments, the esti-
mated DNA copy number concentration (cp/μL) for each of
the aliquots derived from theWVM units and the gDNA units
were based on the reported dilutions, numbers of positive
partitions and analysed partitions. For the QX100 system,
the droplet volume was determined by Corbisier et al. to be
0.834 nL [14], with the QuantStudio 3D, the updated chamber
volume of 0.809 nL was used, while the partition volumes of
the Biomark 37K array were defined by the manufacturer
(ESM, Table S11). The equations used to calculate the initial
DNA copy number concentration were reported in our previ-
ous study [23]. For each aliquot, the estimated DNA copy
number concentration was calculated according to the means
of two replicates analysed in a single experiment.
Statistical analysis
The homogeneity and stability of the gDNA units were deter-
mined using single-factor analysis of variance (ANOVA) in R
studio, version 0.98.977. For the homogeneity study, the mean
DNA copy number concentrations for each of the five gDNA
units were measured (ESM,Method S1, gDNA units H1-H5),
with duplicate measurements for each gDNA unit taken into
account. For the stability study, six replicates were taken into
account for each of three gDNA units (ESM, Method S1,
gDNA units G1-G3) that were also tested as a part of the
inter-laboratory study. For the inter-laboratory study and sta-
bility study, outliers were determined for each instrument in-
dependently, using Grubbs tests (R studio, package ‘outliers’),
and these were excluded from the further analysis. For the
intra-experiment variability, the coefficients of variation
(CVs) were calculated for the duplicates in Excel 2007, by
dividing the standard deviation by the mean DNA copy num-
ber concentration. With the intermediate precision, CVs were
calculated from all measurements performed in three experi-
ments on the same instrument using one gDNA or WVM unit
(n = 6). Statistical analyses of inter-unit variability within a
single instrument, and those that assessed the reproducibility
between the instruments and laboratories, were performed
using ANOVA and Tukey’s tests (R studio). For each instru-
ment and HCMV test material, the estimated mean DNA copy
number concentrations were calculated by taking the means of
all of the data from every unit (WVM units or gDNA units)
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and experiment (Microsoft Excel 2007). To evaluate the dif-
ferences between the reported mean DNA copy number con-
centrations from the different dPCR instruments, ANOVA and
Tukey’s tests were used, in R studio. In addition, the standard
measurement uncertainties were calculated for every instru-
ment and HCMV test material, based on the bottom-up ap-
proach in Eq. (1) [24]:
(i) The measurement uncertainty was calculated as a com-







where ur is the uncertainty associated with the repeatabil-
ity, and uip is the uncertainty associated with the interme-
diate precision.




























where n is the number of independent replicates per ex-
periment, N is the number of experiments performed on
one instrument,MSwithin is the mean square value within
groups and MSbetween is the mean square value between
groups. Both mean squares were calculated using
ANOVA in Microsoft Excel 2007, with all of the mea-
surements taken into account for each experiment, in-
cluding duplicates. If MSbetween >MSwithin, Eq. (3) was
used to calculate the intermediate precision. In contrast,
ifMSbetween <MSwithin, Eq. (4) was used to calculate the
intermediate precision. To obtain the expanded measure-
ment uncertainty, the coverage factor (k) was applied.
The value of the coverage factor was chosen at the
95% level of confidence, based on the degrees of free-
dom (i.e., k = 2.2 for two experiments, each with six
independent replicates [n = 12]; k = 2.11 for three exper-
iments, each with six independent replicates [n = 18]).
For both of the HCMV test materials, the mean DNA copy
number concentrations and the corresponding expanded mea-
surement uncertainties, which took into account themeanDNA
copy number concentration of each instrument, were estimated
according to the guidelines from the Consultative Committee
for Amount of Substance:Metrology in Chemistry and Biology
(CCQM) [25]. To select the most appropriate estimator, the
following were performed: Grubbs test for outliers (R studio);
preliminary graphical inspection to check for over-dispersion of
mean values; mutual consistency check (chi-squared test in
Excel 2007) [25]; and Birge ratio calculation (ESM, Method
S2). For both of the HCMV test materials, estimation of the
mean DNA copy number concentration and the corresponding
measurement was performed using the Vangel-Ruhkin estima-
tor (R studio; package ‘metrology’), which was characterised as
the most appropriate estimation method based on the CCQM
guidelines (ESM, Method S3) [25].
Results and discussion
Central laboratory monitoring of concentration,
homogeneity and stability of gDNA
To assign nominal DNA copy number concentration to the
gDNA material and to define the homogeneity of the gDNA
units, initial monitoring was carried out in laboratory 1. Here,
five gDNA units (units H1–H5) were analysed in duplicate on
a QX100 system immediately after the gDNA extraction from
a single WVM unit (unit W10). The stability of the test batch
was checked during the inter-laboratory study with the analy-
sis of three gDNA units (units G1–G3) that had been stored
for 4 months at −20 °C. The mean DNA copy number con-
centration of the gDNA test material (combined DNA concen-
trations from units H1–H5 and G1–G3) (±expanded standard
error; k = 2.78) was estimated at 979 (±59) cp/μL (ESM,
Fig. S2), and the gDNA units H1–H5 were homogenous in
terms of the DNA copy number concentration (p > 0.41;
ANOVA 95% confidence level). By comparing units G1–G3
with units H1–H5, the stability of the gDNA units after the
4 months of storage at −20 °C was also confirmed (p > 0.9;
ANOVA 95% confidence interval) (ESM, Fig. S2).
Inter-laboratory assessment
The two different HCMV test materials comprised the locally
extracted gDNA from the purchased WVM units (e.g.
Fig. 1A, units W1–W9), and the centrally prepared gDNA
units (e.g. Fig. 1B, units G1–G9) that were distributed to the
participating laboratories. These were each quantified in three
different laboratories using two or three different dPCR plat-
forms (Table 1). In each laboratory, three WVM units and
three gDNA units were tested. From each WVM unit and
gDNA unit, six aliquots were locally prepared, three aliquots
for subsequent analysis on one dPCR platform (laboratories
1–4) and three aliquots for analysis on another dPCR platform
Inter-laboratory assessment of different digital PCR platforms 2607
(laboratories 1, 2). For each dPCR instrument, three aliquots
derived from each of the three WVM units and three gDNA
units were each tested in duplicate in one of three consecutive
experiments (e.g. Fig. 1A, aliquots 1–3 from unit W5 were
tested in experiments 1–3), to determine the intermediate pre-
cision and the inter-unit variability within each dPCR instru-
ment and laboratory. Additionally, for each dPCR instrument,
the mean DNA copy number concentration and the corre-
sponding expanded measurement uncertainty were estimated.
For each of the three WVM units and three gDNA units, three
of the four participating laboratories reported complete data
for the three units tested in three experiments on one or two
dPCR platforms (ESM, Tables S1-S6). The exception here
was laboratory 1, which reported only two complete sets of
data due to technical problems with the Biomark system
(ESM, Table S1). With all of the instruments, the NTCs and
negative extraction controls were negative, except for the
QuantStudio3D system, where one false positive partition
was noted in two NTCs. This can occur due to cross-
contamination between samples or because of non-specific
binding of primers [13]. However, due to the high DNA copy
number concentrations used in this inter-laboratory study, the
occurrence of a single false positive partition in the NTCs did
not bias the subsequent interpretation of the data.
Intra-experiment variability, intermediate precision
and agreement between experiments
For each dPCR instrument, three experiments were per-
formed, each with one of three aliquots derived from each of
three WVM units and three gDNA units, analysed in dupli-
cates. Grubbs tests were used to determine the outliers and
exclude these from the further analysis (ESM, Table S12).
With each of these HCMV test materials, low CVs related to
intra-experiment variability were observed among the differ-
ent dPCR instruments, as the great majority of the duplicates
(e.g. Fig. 1A, two replicates of aliquot 1 from unit W5) had
CV <10%, with some CVs between 10 and 40% mostly for
the Biomark system. The low CVs related to the intra-
experiment variability of the QX100 system and the
Biomark 37K array are in agreement with other reports using
HCMV DNA and bacterial DNA [26, 27]. The higher CVs
observed with the Biomark 37K array compared to the other
two dPCR platforms might have been due to the >25-fold
smaller number of analysed partitions, and/or to pipetting er-
rors related to the smaller sample volumes [23, 27].
With all of the dPCR instruments, low CVs related to in-
termediate precision were noted (CVs below 25%). Moreover,
with each HCMV test material tested with each dPCR instru-
ment, there were no statistically significant differences in the
mean DNA copy number concentration between the three
consecutive experiments, when for each all six measurements
(three units in duplicate) were taken into account
(Fig. 2, ESM, Table S13). The lowCVs related to intermediate
precision are in agreement with previous reports from individ-
ual laboratory data for HCMV DNA and different bacterial
DNA template types [26, 28]. This finding provides additional
Fig. 2 Mean DNA copy number concentration estimated on each of
dPCR instrument involved in quantification of A whole-virus material
(WVM) and B genomic DNA (gDNA). Each symbol denotes a single
measurement of the dPCR platform, whereas black triangles represent
outliers. Dashed lines, mean DNA copy number concentration obtained
on each dPCR instrument in all experiments; dotted lines, expanded mea-
surement uncertainty considering all experiments (Lab 1-Biomark, k =
2.2; all other instruments, k = 2.11)
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support for the indications that dPCR is suitable as a reference
measurement procedure, as it provides very precise quantifi-
cation of viral DNAwithin and between experiments.
Inter-unit variability
With the gDNA test material, each of the four participating
laboratories measured three different gDNA units that were
centrally prepared in laboratory 1. In contrast, for the WVM
test material, the DNA from three WVM units was locally
extracted and analysed in each of the three laboratories. With
all of the dPCR instruments, the centrally prepared gDNA units
showed only minor inter-unit variability, as the differences in
mean DNA copy number concentration between these gDNA
units were below 14% and were mostly not statistically signif-
icant (Table 2; ESM, Fig. S3). On the other hand, for theWVM
units, where the gDNAwas extracted locally, there was higher
inter-unit variability compared to the centrally prepared gDNA
units, with the highest difference between the WVM units with
the Biomark 37 array from laboratory 2, with 55% higher mean
DNA copy number concentration obtained from unit W4 com-
pared to unit W6 (Table 2; ESM, Fig. S4). The low CVs related
to inter-unit variability of the centrally prepared gDNA units
confirms their homogeneity when analysed in each of the par-
ticipating laboratories. This is in agreement with other reports
where simple DNA templates that did not require DNA extrac-
tion were used (e.g. gDNA, plasmid DNA) [28, 29]. Despite
the statistically significant differences between the centrally
prepared gDNA units tested on the QuantStudio 3D system,
there were low CVs related to intra-experiment variability
(CVs for duplicates, <10%) and intermediate precision (CVs
for three experiments, <1%), which explains the statistical sig-
nificance of <12% difference between these gDNA units. With
the WVM material tested in laboratories 1 and 2, most of the
differences between the three analysed WVM units were con-
stant, as they were observed with both dPCR platforms. With
the low filling-volume related uncertainty and high stability of
the WVM units that are claimed by the manufacturer, it is
reasonable to assume that the inter-unit variability was intro-
duced during the DNA extraction, as the DNA was locally
extracted from each individualWVMunit. This is in agreement
with previous studies where up to 50% difference was noted
between DNA-extraction replicates quantified using the same
qPCR assay [30, 31]. With PCR-based DNA quantification,
estimation of DNA copy number concentration can be influ-
enced by variable DNA recovery and/or insufficient removal of
PCR inhibitors during DNA extractions [32]. However, as
dPCR platforms are considered to be relatively robust to poten-
tial inhibitory substances that might have remained during the
DNA extraction [11, 12], it is likely that the differences in the
estimated mean DNA copy number concentration between the
WVM units were mostly caused by variable DNA recovery
upon extraction. This is in agreement with previously reported
data with HCMV, where intermediate variability was noted
Table 2 Inter-unit variability and intermediate precision obtained on
different platforms and instruments. For every unit in each laboratory,
mean DNA copy number concentrations were calculated considering all
duplicate measurements from all experiments (n = 6 or less). p value
denotes statistical significance of differences between units. For each
unit from every laboratory, intermediate precision is calculated as CV


















WVM 1 Biomark 3853 14 3926 7 4526 10 0.10
WVM 1 QX100 3476 2 3870 5 3995 3 <0.001
WVM 2 Biomark 3063 9 2606 31 1973 25 0.02
WVM 2 QX100 3355 5 2532 8 2741 11 <0.001
WVM 3 Biomark 3533 12 3129 10 3182 8 0.10
gDNA 1 Biomark 986 9 1132 6 1053 2 0.060
gDNA 1 QX100 949 7 1002 8 983 3 0.40
gDNA 2 Biomark 941 14 931 13 988 19 0.81
gDNA 2 QX100 1130 7 1128 4 1091 7 0.26
gDNA 4 QuantStudio
3D
987 3 955 6 885 4 0.002
WVM whole-virus material, gDNA genomic DNA
a First unit, WVM: units W1 (laboratory 1), W4 (laboratory 2), W7 (laboratory 3); gDNA: units G1 (laboratory 1), G4 (laboratory 2), G7 (laboratory 4)
b Second unit, WVM: units W2 (laboratory 1), W5 (laboratory 2), W8 (laboratory 3); gDNA: units G2 (laboratory 1), G5 (laboratory 2), G8 (laboratory
4)
c Third unit, WVM: units W3 (laboratory 1), W6 (laboratory 2), W9 (laboratory 3). gDNA: units G3 (laboratory 1), G6 (laboratory 2), G9 (laboratory 4)
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between extraction replicates analysed by dPCRwithin a single
laboratory [20, 31]. With the QX100 system, the differences
between the WVM units had higher statistical significance in
comparison to the Biomark 37K array. This finding suggests
that the QX100 system provides more precise discrimination
between the WVM units. This is due to the lower CVs related
to the intra-experiment variability of the QX100 system com-
pared with the Biomark 37K array, as previously discussed.
Measurement uncertainties of each dPCR instrument
With eachHCMV test material and dPCR instrument, themean
DNA copy number concentrations and corresponding expand-
ed measurement uncertainties were calculated by taking into
account the three WVM units or gDNA units, each of which
was divided into three aliquots that were each measured in one
of three experiments. For every dPCR instrument, small ex-
panded measurement uncertainties (<18%) were obtained for
the centrally prepared gDNA test material, whereas with amore
complex material (i.e. WVM) that requires local DNA extrac-
tion, higher expanded measurement uncertainties (<28%) were
noted (Fig. 2, Table 3). This is in agreement with a previous
inter-laboratory study on bacterial DNA [28]. Additionally, in
two other assessments using simple and well-defined DNA
templates [29, 33], lower expanded measurement uncertainties
(<6%) were observed for the QX200 system, the Biomark
12.765 arrays and other dPCR platforms compared to this
study. Hence, dPCR offers a very precise estimation of the
DNA copy number concentration. However, the final measure-
ment uncertainty is dependent on the complexity of the DNA
material, with the local DNA extraction resulting in additional
uncertainty components, i.e., leading to higher measurement
uncertainty. In the present study, within laboratories 1 and 2,
smaller measurement uncertainties were seen for the QX100
system compared to the Biomark 37K array (Fig. 2, Table 3),
which is in agreement with another report where a QX100
system and a Biomark 12.765 array were compared [33].
This might arise from the higher CVs related to the intra-
experiment variability that was noted on the Biomark 37K
system. As no such differences between the QX100 and the
Biomark 37K arrays were observed in the inter-laboratory
study on bacterial DNA, this might be attributed to the study
setup and pipetting errors [28].
Intra-laboratory agreement
In laboratories 1 and 2, two different dPCR platforms were
used. For both HCMV test materials analysed on the Biomark
37K array in laboratory 1, the mean DNA copy number con-
centration was approximately 8% higher than that measured on
the QX100 system (Table 3). The opposite was noted in labo-
ratory 2, where both of the HCMV test materials showed 17%
lower mean DNA copy number concentrations when measured
on the Biomark 37K array comparedwith thosemeasured using
the QX100 system. The high intra-laboratory agreement be-
tween the QX100 system and the Biomark 37K array has al-
ready been observed in two other studies [23, 27]. Additionally,
low discrepancies were observed between the other dPCR plat-
forms [14, 20, 33].
Within laboratories 1 and 2, the differences between the
QX100 system and the Biomark 37K array were very consis-
tent, as the differences in the DNA copy number concentration
between both of these platforms were similar, regardless of the
HCMV test material used. Similar consistency between these
two platforms has already been noted for three different types
of bacterial DNA [28].
However, there was disagreement noted between laborato-
ries 1 and 2, where for the QX100 system, higher (laboratory 2)
and lower (laboratory 1) mean DNA copy number concentra-
tions were measured compared to the Biomark 37K array.
Although in both laboratories differences between those two
platforms were smaller than expanded measurement uncertain-
ty of each platform, this pattern was noted with both test mate-
rials. Similar inconsistent data have been reported previously
for plasmid DNA [28], which suggests that such discrepancies
between platforms are not always systematic, but can be ran-
dom; however, the reasons for such random discrepancies are
not yet completely understood. As the same assay, and the
same HCMV test materials and cycling conditions were used
in all of the laboratories, over-estimation and under-estimation
of the DNA copy number concentrations and discrepancies
between laboratories might be due to either the use of different
master mixes, or to incorrectly assigned partition volumes [15,
23, 27]. For both dPCR platforms, various lot numbers of the
particular master mixes were used in the different laboratories,
which might partially contribute to these observed discrepan-
cies between the platforms. With the QX100 system and the
Table 3 Estimated mean DNA copy number concentrations and
expanded measurement uncertainties





















1 Biomark 4101 13 1058 11
1 QX100 3780 8 974 7
2 Biomark 2547 28 953 18
2 QX100 2867 15 1114 6
3 Biomark 3281 10 / /
4 QuantStudio
3D
/ / 942 7
a Biomark from laboratory 1, k = 2.20; all other instruments, k = 2.11
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Biomark 12.765 array, >10% difference in partition volume
was reported from an independent assessment carried out in
several laboratories [14, 33–35]. Furthermore, with the
Biomark 12.765 array, around a 7% difference in chamber
volume was found between two arrays measured in the same
laboratory [36]. The discrepancy between the QX100 system
and the Biomark 37K array observed in the present study might
therefore arise from variable partition volumes of the different
Biomark 37K array lots and/or differences between droplet
volumes generated and analysed for the QX100 systems from
different laboratories.
Inter-laboratory agreement and mean DNA copy number
concentrations
The mean DNA copy number concentrations for each HCMV
test material were measured on each dPCR instrument (i.e. two
QX100 systems, two Biomark systems, one QuantStudio 3D)
from the four laboratories. With the gDNA test material, the
differences between the laboratories did not exceed the differ-
ences within each laboratory, as the maximum difference in
mean DNA copy number concentration between the dPCR
instruments from two laboratories was <20% (Table 3).
Furthermore, no statistically significant differences were ob-
served between the majority of the instrument pairs (ESM,
Fig. S5A). Between laboratories 1 and 2, there was only a
minor difference in mean DNA copy number concentrations
when the mean DNA copy number concentrations from the
dPCR platforms within each laboratory were taken into ac-
count. Conversely, with the more complex DNA material of
WVM, a 62% difference in the mean DNA copy number con-
centration was noted between the two Biomark instruments
from different laboratories (Table 3), with statistically signifi-
cant differences between most of these instrument pairs (ESM,
Fig. S5B). Furthermore, in laboratory 1, approximately 40%
higher mean DNA copy number concentrations were noted
when compared to laboratory 2.
With the gDNA test material, the good agreement between
the laboratories additionally demonstrated the high stability of
the gDNAunits distributed to the participating laboratories. The
reasons for minor discrepancies between instruments and labo-
ratories are still not well understood; however, they were prob-
ably primarily caused by each individual dPCR instrument, due
to over-estimation or under-estimation of DNA copy number
concentration, and are not directly influenced by factors related
to the different laboratories. In contrast to the centrally prepared
gDNA test material, the WVM required local DNA extraction
before DNA quantification. DNA extraction has already been
demonstrated to introduce an additional variability (CV up to
50%) due to differences in DNA recoveries from extraction
columns of the samemanual extraction kit used by one operator
within one laboratory [20, 30, 31]. To the best of our knowl-
edge, no inter-laboratory assessment of the same DNA
extraction method for quantification of viral DNA has been
performed. However, it can be speculated that different opera-
tors from different laboratories would contribute to this variabil-
ity. Another source of variability might be differences in com-
position between the suggested in-house prepared PBS (labo-
ratory 1) and the purchased commercial PBS (laboratories 2–4),
as it has been shown that the matrix can have an impact on the
DNA recovery and the variability of DNA extractions [20].
Therefore, it is reasonable to assume that in the present study,
the local DNA extractions from WVM performed individually
in each laboratory contributed to the higher discordance be-
tween the laboratories and instruments than for those observed
with the centrally prepared gDNA.
To additionally demonstrate the suitability of dPCR as a
candidate reference measurement procedure of higher metro-
logical order, its applicability for value assignments of different
virus reference materials was determined. For each material,
the Vangel-Ruhkin estimator was selected based on several
criteria published in the CCQM guidelines [25] (ESM,
Method S3, Tables S14, S15). With both materials, the data
from all five of the dPCR instruments fell within narrow ex-
panded measurement uncertainties (WVM, 15%; gDNA, 6%)
of the mean DNA copy number concentrations (Fig. 3).
As the low measurement uncertainties observed in the pres-
ent study are in agreement with two other inter-laboratory as-
sessments that used bacteriophage DNA and different types of
bacterial DNA [28, 29], we can conclude that dPCR offers good
reproducibility for quantification of DNA of different complex-
ities (e.g. plasmidDNA, gDNA,whole bacteria and viruses) and
from different sources (e.g. viruses, bacteria, bacteriophages). To
determine the suitability of dPCR as a reference measurement
procedure and for characterisation of certified reference mate-
rials, the performance of dPCR should be compared to that of
the qPCR method that is currently used for characterisation of
virus reference materials [8]. The use of qPCR in several inter-
laboratory studies for the quantification of HCMV resulted in
more than 100-fold differences between laboratories in terms of
the DNA copy number concentration [2, 8]. Themain reason for
this variability is most probably the disparity in the quantifica-
tion procedures between the participating laboratories, as differ-
ent assays and DNA extraction methods, and variable calibra-
tion procedures, can exacerbate the agreement between labora-
tories in terms of estimated DNA copy number concentration. In
contrast to qPCR, several dPCR platforms have already been
shown to be resilient to inhibitors and resistant to the influence
of different PCR components, hence allowing for more accurate
and robust quantification of DNA than is possible with qPCR
[11, 23, 27]. The variability caused by the DNA extraction
method in particular should receive special attention when
dPCR is considered as a candidate for a reference measurement
procedure and for characterisation of reference materials. The
accuracy and robustness of dPCR-based DNA quantification
can be further improved by preliminary selection of the DNA
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extractionmethod with the highest DNA recovery, while extrac-
tion replicates would probably reduce the influence of inter-
column variability. Moreover, DNA recovery of the selected
extraction method should be assessed to allow the inclusion of
extraction related variability into themeasurement uncertainty of
quantification of the whole-virus reference material.
Furthermore, where possible, dPCR-based direct quantification
can bypass most of the mentioned problems, including inter-
laboratory variability caused by the different operators of the
extraction and clean up procedures, as this does not require
DNA extraction and has been demonstrated to provide accurate
and repeatable quantification of DNA derived from different
whole-virus reference materials [20].
Conclusions
To the best of our knowledge, the present study represents the
first inter-laboratory assessment of different dPCR platforms
for quantification of viral DNA. Two HCMV test materials, as
WVM for local extraction and centrally prepared (extracted)
gDNA, were selected to determine the repeatability, interme-
diate precision, and agreement in the quantification within and
between laboratories (reproducibility) when using different
dPCR platforms and instruments. For each dPCR instrument,
good precision was seen. Furthermore, less than twofold dif-
ferences in the estimated mean DNA copy number concentra-
tion were observed between dPCR platforms from different
laboratories. As a consequence, when measurements from all
participating dPCR instruments were considered, with both of
these HCMV test materials, the mean DNA copy number
concentrations were estimated with small expanded measure-
ment uncertainties. All of these findings indicate that dPCR
offers very repeatable (i.e. within instrument) and reproduc-
ible (i.e. between instruments, platforms and laboratories)
quantification of viral DNA. This demonstrates that dPCR
has the potential for implementation in the metrological
framework as a measurement reference procedure, if correctly
validated DNA extraction and quantification can be assured.
In their current format, such methods could enable reproduc-
ible production of reference materials. They could also be
applied to value assign secondary reference materials for cal-
ibration of the qPCR methods that are widely used.
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